Drug
Taspoglutide
Taspoglutide: highest development phase Phase 2, developed by Roche. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Roche
Trials
| Drug | Phase | Indication |
|---|---|---|
| taspoglutide NCT00423501 | Phase 2 | Diabetes Mellitus Type 2 |
Latest
No recent events.
Follow Taspoglutide on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.